Join our community of smart investors

Haleon regains momentum after inflationary spike

The maker of Sensodyne toothpaste appears less vulnerable to down-trading than its peers
February 29, 2024
  • Share buyback and dividend increase announced
  • Margins improve in Q4

After a disappointing performance by rival Reckitt Benckiser (RKT), revenue and profit growth at Haleon (HLN) looks all the more impressive to investors. Shares in the consumer health giant climbed 8 per cent on the morning of its annual results, despite some lingering concerns about its debt burden.

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in